Liquichek 546
Liquichek 546 is a Class I device made by Bio-Rad Laboratories, cleared under FDA 510(k) K955024 on 28 Nov 1995 and listed in FDA GUDID since 14 Sep 2020 (UDI-DI 00847661000969), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00847661000969 | Date14 Sep 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK955024 | Date28 Nov 1995 | StatusActive |
Official records
- AccessGUDID record 00847661000969
- FDA 510(k) database K955024
Across registries
- FDA 510(k) K955024 decided 28 Nov 1995 Active
- FDA GUDID UDI-DI 00847661000969 listed 14 Sep 2020 Listed
Timeline
- Cleared FDA 510(k) K955024
- Listed FDA GUDID 00847661000969
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Liquichek
- Generic name
- Ammonia IVD, control
- Model / Ref / Catalog
- 546
- Primary DI / UDI-DI
- 00847661000969
- 510(k) Number
- FDA product code
- JJY
- GMDN term
- Ammonia IVD, control
- Device class
- Class I
- Regulation number
- 862.1660
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code JJY (Multi-analyte controls, all kinds (assayed)).
- CALIBRATION VERIFICATION KIT OR CVK by RADIOMETER AMERICA, INC.
- IMMUNOASSAY PLUS CONTROL, LEVELS 1, 2, AND 3 by Consolidated Technology
- SERONORM LIPID by Nyegaard & Co. A/S
- VENTREZYME EIA CONTROLS-IMMUNOASSAY by Ventrex Laboratories, Inc.
- DOCUMENT(TM) TOTAL AND DIRECT BILIRUBIN LINEARITY by Casco Standards
- LIPID CONTROL by Medical Analysis Systems, Inc.
- VALIDATE GC1, GC2, GC3 AND GC4 CALIBRATION VERIFICATION/LINEARITY TEST SET by Maine Standards Co.
- LIQUID CSF(LCR)1, LIQUID CSF(LCR)2 by Chiron Diagnostics Corp.
- AMERLITE TOTAL THYROID CONTROL SERA LAN.4001 by Amersham Corp.
- CHEMISTRY CONTROL N & A by Integrated Medical Systems Int'L., Inc.